These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14621870)

  • 1. Adjuvant treatment with ursodeoxycholic acid prevents acute rejection in rats receiving heart allografts.
    Olausson M; Mjörnstedt L; Wramner L; Persson H; Karlberg I; Friman S
    Transpl Int; 1992; 5 Suppl 1():S539-41. PubMed ID: 14621870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejection.
    Bährle S; Szabó G; Stiehl A; Theilmann L; Dengler TJ; Zimmermann R; Kübler W
    J Heart Lung Transplant; 1998 Jun; 17(6):592-8. PubMed ID: 9662095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of regulatory T cells and indefinite survival of fully allogeneic cardiac grafts by ursodeoxycholic acid in mice.
    Zhang Q; Nakaki T; Iwami D; Niimi M; Shirasugi N
    Transplantation; 2009 Dec; 88(12):1360-70. PubMed ID: 20029332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental study on the effect of ursodeoxycholic acid in liver transplantation].
    Nozaki H
    Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1481-8. PubMed ID: 1287461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nordic multicenter double-blind randomized controlled trial of prophylactic ursodeoxycholic acid in liver transplant patients.
    Keiding S; Høckerstedt K; Bjøro K; Bondesen S; Hjortrup A; Isoniemi H; Erichsen C; Söderdahl G; Ericzon BG
    Transplantation; 1997 Jun; 63(11):1591-4. PubMed ID: 9197351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection.
    Barnes D; Talenti D; Cammell G; Goormastic M; Farquhar L; Henderson M; Vogt D; Mayes J; Westveer MK; Carey W
    Hepatology; 1997 Oct; 26(4):853-7. PubMed ID: 9328304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation.
    Friman S; Persson H; Scherstén T; Svanvik J; Karlberg I
    Transpl Int; 1992; 5 Suppl 1():S187-9. PubMed ID: 14621771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive effects of ursodeoxycholic acid in heart-allografted rats.
    Bährle S; Szabó G; Dengler TJ; Zimmermann R; Hagl S; Kübler W
    Transplant Proc; 1998 May; 30(3):864-5. PubMed ID: 9595128
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue-specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats.
    Vriens PW; Nisco SJ; Hoyt EG; Lyu SC; Pierre P; Reitz BA; Clayberger C
    Transplantation; 1994 Jun; 57(12):1795-8. PubMed ID: 8016886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
    Grinyó JM; Gil-Vernet S; Seron D; Hueso M; Fulladosa X; Cruzado JM; Moreso F; Fernandez A; Torras J; Riera L; Castelao AM; Alsina J
    Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular mechanisms underlying differential rejection of sequential heart and lung allografts in rats.
    Moller F; Hoyt G; Farfan F; Starnes VA; Clayberger C
    Transplantation; 1993 Mar; 55(3):650-5. PubMed ID: 8456486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithymocyte globulin and cyclosporin A are synergistic in an experimental transplantation tolerance model in the rat.
    Olausson M; Lukes D; Norrby J; Qi Z; Ekberg H; Gannedahl G; Tufveson G; Mjörnstedt L
    Scand J Immunol; 1999 Jan; 49(1):38-44. PubMed ID: 10023855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
    Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN
    Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, double-blind trial evaluating the efficacy of ursodeoxycholic acid in prevention of liver transplant rejection.
    Fleckenstein JF; Paredes M; Thuluvath PJ
    Liver Transpl Surg; 1998 Jul; 4(4):276-9. PubMed ID: 9649640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials.
    Deng YL; Xiong XZ; Cheng NS
    Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):464-73. PubMed ID: 25308356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart allograft rejection in rats triggered by H2 inhibitors.
    Olausson M; Wramner L; Blohmé I; Mjörnstedt L
    Transplant Proc; 1997 Nov; 29(7):3127-8. PubMed ID: 9365695
    [No Abstract]   [Full Text] [Related]  

  • 18. The suppression of heart and liver allograft rejection by liver suppressor factor one (LSF-1) and its possible human homologue.
    Goto S; Lord R; Shimizu Y; Edwards-Smith C; Vari F; Chiba S; Kobayashi S; Pan TL; Akiyama K; Kuwahara T; Yuda H; Goto T; Chiang KC; Lin YC; Chen CL
    Transplant Proc; 1998 Nov; 30(7):3578-9. PubMed ID: 9838567
    [No Abstract]   [Full Text] [Related]  

  • 19. A possible role of ursodeoxycholic acid in liver transplantation.
    Friman S; Svanvik J
    Scand J Gastroenterol Suppl; 1994; 204():62-4. PubMed ID: 7824880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive immunosuppressive effect of hydroxycamptothecin and cyclosporine on rejection of heart transplantation in rats.
    Shi B; Cai M; Qian Y; Zhou W; Mo C; Wang Y
    Transplant Proc; 2007 Dec; 39(10):3429-31. PubMed ID: 18089398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.